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Automation of the Assay for Transglutaminase
DONALD D. CLARKE and RUTH NICKLAS
Transglutaminase is an enzyme which catalyzes the
Ca++-activated incorporation of amines into proteins ( 1,2). More detailed studies of the action of
this enzyme showed that the incorporated amines
displaced ammonia ( 3), and that only L-glutamine
and not asparagine residues in the protein or peptide are substrates for this enzyme ( 4). This enzyme
will not act on free glutamine, hence is not to be
confused with glutaminase or transamidases which
will act on free glutamine as a substrate. A variety
of substituted glutamine peptides have been found
to have substrate activity for this enzyme. Neidle
and Acs ( 5), and more recently Folk and Cole ( 6),
have studied the effects of varying the nature of the
amino acids surrounding the active glutamine residue. While the nature of the amino acid present
will alter the quantitative response of the given
peptide as a substrate, a large number of protected
glutamine dipeptides seem to possess substrate
activity.
There are other factors which must be· involved
in determining the substrate specificity of a glutamine peptide as there are some proteins which, in
the native state, do not act as substrates for transglutaminase but do so on denaturation. Thus, in
Zn-free insulin, only the two glutamine residues of
the A chain seem to react readily (7), while after
oxidation of the chains, the glutamine residue in
the B chain is quite a good substrate for transglutaminase (5). With hemoglobin, no substrate
activity appears until the protein is denatured, and,
in addition, a detailed study by Pincus (8) has shown
that certain glutamine residues in the protein do
not act as substrates for transglutaminase, even
after denaturation. (These are the residues which
are foB owed by lysine and arginine.)

Materials and Methods
In our early experiments in the late Professor
Heinrich Waelsch's laboratory, we used the incorporation of C 1 ~-labeled amines to assay enzyme
activity. In these assays, we were able to show that
hydroxylamine very effectively competes with the
labeled a mines ( 1). This prompted us to use hydroxylamine as the replacing amine ( 9) and to
measure the extent of reaction by use of the fact
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that ferric hydroxamates have an absorption maximum at 525 mi-l, while the excess of unreacted hydroxylamine shows no absorption of light in this
range. This method has been a favorite of biochemists since Lipmann and Tuttle ( 10) employed
it some 25 years ago.
For the colorimetric assay, a soluble peptide was
more suitable than a protein, and we found that the
commercial tryptic digest of casein was a suitable
substrate. N-Z amine Type E, of the Sheffield Co.,
was the n1aterial which we found to be most suitable in our studies. It was extracted into 80%
ethanol to separate some of the higher molecular
weight material. The fraction of the peptides soluble in 80% ethanol was evaporated to a small
volun1e and made up to 300 mg/ ml by weight, and
used as the standard substrate for our work. We
have been using a manual assay based on these observations for the past few years ( 1 1).
Our interest in automating the manual assay
springs from our studies on the possible physiological role of transglutaminase. Insofar as transglutaminase can modify proteins, it would seem
that it may function in autoimmune processes in
which a protein normally found in an organism may
be converted into a foreign protein. The replacement of some of its amide groups or the crosslinking of the lysine e-amino groups from one peptide
chain with the glutamine residues of the same or
another peptide chain, reactions which can be
catalyzed by this enzyme, might convert certain
proteins in an organism to foreign bodies. Some
means of preventing such a process from occurring
very frequently must be available to the organism
or it would not long survive. We have therefore
been attempting to study the action of transglutaminase under a variety of physiological conditions
where it could possibly function. Our preliminary
studies showed that injection of large quantities of
labeled amines into guinea pigs, rats, or mice did
not lead to a very significant incorporation of these
amines into protein of liver or other organs ( unpublished observations). This is in contrast to in
vitro experiments where it is extremely easy to
demonstrate very considerable incorporation of
amines into the proteins of various organs, especially the liver.
In studying some of the conditions which modify
the immune response in animals, we were able to
show that injections of B. pertussis into mice, a
treatment which has been reported to increase the
sensitivity of these animals to histamine, resulted in
an increase in the level of transglutaminase activity in the livers of these animals. An increase of
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100% was usually observed in 16 to 24 br after
an injection of B. pertussis vaccine. With two or
more injections, increases of up to 200% could be
obtained ( 12) .
In parallel experiments, Wajda, Ginsburg and
Waelsch ( 13) were able to show that the incorporation of radioactive histamine into the liver proteins of mice, while small, did parallel the level of
transglutaminase in the livers of these animals.
We have made preliminary attempts to determine whether or not this increase in the level of
liver transglutaminase in mice which occurs in response to injection of B. pertussis or a variety of
bacterial endotoxins is related to an increase of the
enzyme protein. To do this, we have injected radioactive amino acid and measured the incorporation
of this amino acid into the partially purified enzyme
protein. However, such experiments could not be
interpreted because of the drastic changes in the
levels of the free amino acid pools in the animals
injected with endotoxin (unpublished observations).
This appeared to be related to the toxic effects of
the endotoxin. We therefore decided to investigate
the reports of Noll and Braude ( 14) that, by treatment of endotoxins with LiAIH4 , it was possible to
produce a material which was no longer toxic but
still retained its antigenic activity. Such a preparation was also able to elicit an increase in the level
of transglutaminase. However, the yield of nontoxic
material is rather low.
We have embarked on a project to separate the
toxic material from the "transglutaminase factor."
This has necessitated a large number of enzyme assays for transglutaminase activity, and we decided
to look into automating this enzyme assay. The
manual assay was adapted to the Technicon AutoAnalyzer (Fig. 1) with the help of Dr. Nathan
Gochman of Technicon Instruments Corp. Because
of the low permeability of the dialyzer membrane
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to oligopeptides, we attempted to use the continuous-filter module, but found that it was rather
easily clogged by the protein precipitate. In addition, the high values of the blanks made this procedure look unattractive.
The dialyzer, on the other hand, gave low blanks
with a very stable baseline which made it the more
attractive method. While double dialysis improved
the sensitivity, there was a corresponding decrease
in the stability of the baseline. We therefore rearranged the manifold to cut in half the overall rate
of flow through the system, and thus to double the
residence time in the dialyzer. At the same time, to
improve the sensitivity of the method, we decreased
the volume of FeCI 3 reagent added to the effluent
from the dialyzer.
The efficiency of dialysis as measured with synthetic carbobenzoxy-y-glutamylhydroxamic acid
was about 25%. A further improvement was obtained by treating the Type C dialyzer membrane
with 66% ZnC1 2 solution, as described by McBain
and Stuewer ( 15) to improve the permeability
of the membrane to the peptide hydroxamates (see
below). While the method at this stage was satisfactory for use with the transglutaminase from
guinea pig liver (GPL) supernatant fraction, it was
still rather insensitive for use with mouse liver
100,000 g supernatants which have only about 1I 10
the specific activity of transglutaminase as GPL.
We therefore resorted to the use of a range expander and this has proved satisfactory, since the
baseline is quite stable.
Preparation of Zinc Chloride Treated Dialyzer
Membranes
A solution of zinc chloride (A.C.S. Reagent,
Granular obtained from Matheson, Coleman and
Bell, Inc.) was prepared by dissolving 400 grams
of this compound in 200 ml of distilled water. This
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Figure 1

Clarke and Nicklas: Automation of Transglutaminase Assay
is 66.6% w/w. A glass dish (8-in. pie plate) was
covered with a thin layer of this viscous solution
and the central portion of a Type C Dialyzer membrane was laid on this solution with the ends extending over the side of the dish. Additional zinc
chloride solution was poured over the top of the
1nembrane and the dish gently tilted and rotated for
a period of 2 min. After 2 min (this timing is
critical), the zinc chloride solution was decanted
rapidly and the membrane floated on distilled water. Distilled water was added on top of the membrane. Precipitation occurred. The membrane was
left in the distilled water with gentle tilting and
rotation of the dish until it was hard enough to be
handled (about one minute). The water was decanted. The above washing procedure was repeated
using 3 N HCl in place of water. The membrane
was then washed with water as before. No precipitate should be observed at this wash. Additional
washing with water may be carried out but was
found to be unnecessary. The membrane was then
placed on the edge of a table as described by the
Technicon manual. At this point, it was smeared
with glycerine to improve the handling qualities.
When placing the membrane on hoops great care
has to be taken as it is considerably more fragile
than untreated membranes. The treated membrane
should be as smooth as possible before the hoops
are closed. Any pulling on the membrane to stretch
it once the hoops are closed usually leads to tearing of the membrane. The bubble patterns obtained
with treated membranes should be as uniform as
those obtained with untreated membranes.
Reagents
Sample: Mouse liver (approximately 1 gram
each) is homogenized with 3.5 ml of 0.25 M sucrose
solution, using a Potter-Elvejhn type of homogenizer at ooc. The homogenate is centrifuged for
one hour at 20,000 rpm (approximately 50,000 g)
in a Spinco Model L Ultracentrifuge. The supernatant fluid is removed with a Pasteur pipet to
avoid disturbing the lipid layer on the surface. Dilutions of 1/10, 3/10, and 1/2 are prepared, using
cold 0.25 M sucrose solution. These dilutions are
added to the sample cups for assay.
Substrate: An enzymatic hydrolysate of casein is
extracted with 80% ethanol as described in Methods of Enzymology ( 11). The final concentration
is adjusted to 300 mg/ ml of mixed pep tides and
amino acids. Seventy-five milliliters of such a solution is mixed with 30 ml of Tris buffer ( 0.1 M and
adjusted to pH 8.0 with HCI), 7.5 ml of calcium
chloride solution (0.1 M adjusted to pH 8.0), and
7.5 ml of water. Brij (Technicon's preparation) is
added at the level of 0.5 ml /liter of solution. The
stock solutions used here may be stored in the
refrigerator indefinitely.
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Hydroxylamine: 12.5 ml of 1 M hydroxylamine
hydrochloride solution is adjusted to pH 8 by addition of 1 N NaOH and the final volume made up
to 25 ml. This solution must be neutralized just
before each run. The neutralized solution cannot
be stored, but the stock solution of hydroxylamine
hydrochloride is kept refrigerated for an indefinite
period.
Ferric Chloride: 300 ml of 5% ferric chloride
solution (FeC13 • 6H20 in 0.1 N HCl) is mixed
with 300 ml of approximately 3 N HCl ( 1 vol. of
cone. HCl plus 3 vol. of distilled water) and 300
ml of distilled water. Brij is added at the level of 0.5
ml/1iter. This solution may be stored at room ternperature indefinitely.
Results
In our studies with the manual assay, we observed that zero time or no enzyn1e blanks was
not satisfactory. Rather, measuring different levels
of enzyme activity and extrapolating back to zero
enzyme yielded better results. On the AutoAnalyzer
we adopted I :5 dilutions of the mouse liver 10,000
g supernatant, with 0.25 M sucrose as the blank
corresponding to each sample.
Enzyme units are calculated on a relative basis
from a standard curve, and, with each run, a sample from a master batch of GPL transglutaminase
is included. This master batch is calibrated by the
manual assay in which a unit of enzyme activity is
defined as that quantity which produces a change
of 0.001 O.D. unit at 525 mp./ 10 min in a final
assay volume of 3.5 ml. Specific activity is defined
as the number of enzyme units per n1illigram of
protein where protein is determined by the biuret
method using bovine serum albumin as the standard. We have adapted the AutoAnalyzer procedure
recommended in the Technicon manual for the determination of protein by the biuret method ( 16).
Transglutaminase Manifold:
See flow diagram (Fig. 1)
One problem which has not been satisfactorily
solved is keeping the enzyme samples cold to minimize inactivation of transglutaminase. It would be
useful to keep the samples cold while they are sitting in the sampler. In addition, the substrate used
as the mixture of glutamine peptides in a commercial tryptic hydrolysate of casein is a potential
source of problems, and we are now looking for a
suitable synthetic peptide which will assure us of
a more certain and reproducible source of substrate.
Currently, the synthetic peptides with optimal .substrate activity are carbobenzoxyglutamine dipeptides which are not sufficiently water soluble for this
use.
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